MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.524
+0.024 (4.76%)
Dec 20, 2024, 4:00 PM EST - Market closed
MiNK Therapeutics Employees
MiNK Therapeutics had 31 employees as of December 31, 2023. The number of employees decreased by 6 or -16.22% compared to the previous year.
Employees
31
Change (1Y)
-6
Growth (1Y)
-16.22%
Revenue / Employee
n/a
Profits / Employee
-$444,526
Market Cap
20.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31 | -6 | -16.22% |
| Dec 31, 2022 | 37 | 4 | 12.12% |
| Dec 31, 2021 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Concord Medical Services Holdings | 727 |
| Bionano Genomics | 344 |
| Bolt Biotherapeutics | 100 |
| BioLineRx | 79 |
| Affimed | 76 |
| NKGen Biotech | 63 |
| American Shared Hospital Services | 31 |
| Citius Pharmaceuticals | 22 |
INKT News
- 3 days ago - MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting - GlobeNewsWire
- 5 weeks ago - MiNK Therapeutics, Inc. (INKT) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 5 weeks ago - MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report - GlobeNewsWire
- 6 weeks ago - MiNK's iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024 - GlobeNewsWire
- 7 weeks ago - MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors - GlobeNewsWire
- 2 months ago - MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors - GlobeNewsWire
- 2 months ago - MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024 - GlobeNewsWire
- 3 months ago - MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference - GlobeNewsWire